Ocean Biomedical

OCEA43

Penny Stock

$1.01arrow_drop_up2.02%$0.02

Penny Stock

OCEA43

$1.01

arrow_drop_up2.02%$0.02

Penny Stock

Performance History

Key Stats
Open	$0.97
Prev. Close	$0.99
EPS	-3.00
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$33.95M
PE Ratio	-

	LOW	HIGH
Day Range	0.95	1.05
52 Week Range	0.52	7.79

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-3.00

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Ocean Biomedical (OCEA)

Ocean Biomedical, Inc. (OCEA) is a publicly traded company in the biotechnology industry. The company specializes in the development and commercialization of innovative medical devices and therapies. With a focus on ocean-inspired technologies, Ocean Biomedical aims to address unmet medical needs and improve patient outcomes. The company's stock price history shows a steady upward trend over the past few years, reflecting investors' confidence in its promising products and technologies.

The current quote for Ocean Biomedical, Inc. (OCEA) indicates the market value of a single share. Investors can track this quote to stay informed about the company's stock performance. By analyzing the stock news, investors can gain insights into recent developments, such as regulatory approvals, clinical trial results, or partnerships. This information helps investors assess the potential impact on the company's valuation and make informed investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Ms. Elizabeth Ng M.B.A.
Headquarters: Providence
Employees: 0
Exchange: NASDAQ

Keep an eye on Ocean Biomedical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Ocean Biomedical (OCEA) stock price performance year to date (YTD)?

As of the latest data, Ocean Biomedical (OCEA) has a year-to-date price change of 63.93%. Over the past month, the stock has experienced a price change of -6.48%. Over the last three months, the change has been -35.26%. Over the past six months, the figure is -75.06%.

help

What is Ocean Biomedical's (OCEA) price per share?

The current price per share for Ocean Biomedical (OCEA) is $1.01. The stock has seen a price change of $0.02 recently, indicating a 2.02% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Ocean Biomedical (OCEA)?

For Ocean Biomedical (OCEA), the 52-week high is $7.79, which is 671.29% from the current price. The 52-week low is $0.52, the current price is 94.23% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Ocean Biomedical (OCEA) a growth stock?

Ocean Biomedical (OCEA) has shown an average price growth of 0.41% over the past three years. It has received a score of 3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ocean Biomedical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is Ocean Biomedical (OCEA) a profitable company?

Ocean Biomedical (OCEA) has a net income of -$958.43K, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$2.48M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Ocean Biomedical (OCEA)?

Ocean Biomedical (OCEA) has a market capitalization of $33.96M. The average daily trading volume is 32.97K, indicating the stock's liquidity and investor engagement.

News

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

PRESS RELEASES

6/5/2024

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PRESS RELEASES

5/30/2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

PRESS RELEASES

5/16/2024

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

PRESS RELEASES

4/24/2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL

PRESS RELEASES

3/28/2024

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL